- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate to Severe Chronic Kidney Disease
Total 5271 results
-
Renalytix AI, Inc.Active, not recruitingDiabetic Kidney Disease | Chronic Kidney Disease, Stage 3 (Moderate) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1United States
-
Glenmark Specialty S.A.CompletedMild to Moderate Chronic Obstructive Pulmonary Disease (COPD)United States
-
Everstar Therapeutics LimitedActive, not recruitingModerately to Severely Active Ulcerative ColitisChina
-
Actavis Inc.Watson Laboratories, Inc.CompletedBACTERIAL VAGINOSIS | Signs and Symptoms to be Evaluated and Recorded Include | Vaginal Discharge Color, Odor, and Consistency | Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe | Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or SevereUnited States, Dominican Republic, Puerto Rico
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingModerate to Severe Acute PainChina
-
University of California, IrvineRecruiting
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Imperial College LondonNational Institute for Health Research, United Kingdom; Imperial College Healthcare...WithdrawnMyocardial Fibrosis | Heart Failure | End Stage Renal Failure on Dialysis | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe)United Kingdom
-
Novartis PharmaceuticalsCompletedMild to Moderate HypertensionGermany
-
SanofiRegeneron PharmaceuticalsRecruitingModerate to Severe Atopic DermatitisCanada
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingModerate to Severe Atopic DermatitisChina
-
Keymed Biosciences Co.LtdRecruitingModerate-to-severe Atopic DermatitisChina
-
Galderma R&DRecruitingModerate-to-Severe Atopic DermatitisUnited States, Denmark, Hungary, Poland, Spain
-
Shanghai Hengrui Pharmaceutical Co., Ltd.CompletedModerate to Severe Atopic DermatitisChina
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Keymed Biosciences Co.LtdCompletedModerate-to-severe Atopic DermatitisChina
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasTerminatedModerate to Severe Atopic DermatitisUnited States
-
Technische Universität DresdenCompletedModerate to Severe Atopic DermatitisGermany
-
Alnylam PharmaceuticalsNot yet recruitingMild to Moderate Hypertension
-
Hospices Civils de LyonCompletedModerate to Severe Traumatic Brain InjuryFrance
-
Augusta UniversityTerminatedChronic Kidney Disease | Chronic Periodontitis, Generalized, ModerateUnited States
-
Action Against Hunger USAUniversity of Washington; Ethiopian Public Health InstituteNot yet recruitingModerate Acute Malnutrition | Severe Acute Malnutrition
-
PfizerRecruitingHealthy Volunteers | Moderate Hepatic Impairment | Severe Hepatic ImpairmentUnited States
-
Bristol-Myers SquibbCompletedModerate Liver Impairment | Severe Liver ImpairmentUnited States
-
Microbiome Health Research InstituteUniversity of Cape TownTerminatedModerate Acute Malnutrition | Severe Acute MalnutritionSouth Africa
-
Novartis PharmaceuticalsGenentech, Inc.CompletedModerate to Severe Allergic AsthmaUnited States, Puerto Rico
-
medac GmbHNot yet recruitingModerate to Severe Atopic Dermatitis
-
Guangzhou JOYO Pharma Co., LtdChengdu JOYO pharma Co., Ltd.Not yet recruitingModerate-to-severe Atopic Dermatitis
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Australia, Canada
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Recruiting
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Enrolling by invitationModerate to Severe Atopic DermatitisChina
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
Royal Victoria InfirmaryBritish Skin FoundationCompletedModerate to Severe Atopic EczemaUnited Kingdom
-
Jiangsu vcare pharmaceutical technology co., LTDRecruitingModerate to Severe Atopic DermatitisChina
-
Keymed Biosciences Co.LtdRecruitingModerate-to-severe Atopic DermatitisChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Not yet recruiting
-
Keymed Biosciences Co.LtdRecruiting
-
Technische Universität DresdenRecruitingModerate-to-severe Atopic DermatitisGermany
-
Inmagene LLCTerminatedAtopic Dermatitis | Moderate-to-severe Atopic Dermatitis | ADCanada, United States
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada
-
Galderma R&DWithdrawn
-
Regeneron PharmaceuticalsSanofiCompletedModerate-to-severe Atopic DermatitisUnited States
-
Keymed Biosciences Co.LtdCompletedModerate-to-severe Atopic DermatitisChina
-
Qurient Co., Ltd.CompletedModerate to Severe Atopic DermatitisUnited States
-
Shanghai Vinnerna Biosciences Co., Ltd.Sponsor GmbHTerminatedModerate to Severe COVID-19China, Uzbekistan
-
Novartis PharmaceuticalsCompletedModerate and Severe Plaque PsoriasisUnited States, Argentina, Germany, Belgium, Italy, United Kingdom, Turkey, Guatemala, Australia